Zura Bio Change To Liabilities Over Time
| ZURA Stock | 2.46 0.18 7.89% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Zura Bio Performance and Zura Bio Correlation. Zura |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.57 | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Change To Liabilities Analysis
Compare Zura Bio Limited and related stocks such as Merit Medical Systems, Cleantech Power Corp, and Ecoloclean Industrs Change To Liabilities Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MMSI | 465 K | 12.2 M | 12.2 M | 11.5 M | 11.5 M | 14.8 M | (6.8 M) | 417 K | 15.7 M | (2.3 M) | 333 K | 6 M | 12.7 M | 14.6 M | 15.3 M |
| ECCI | 227.4 K | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (81.3 K) | (73.2 K) | (69.5 K) |
| PINS | 12 M | 12 M | 12 M | 12 M | 12 M | 12 M | 12 M | 12 M | 6.5 M | 11.6 M | 39.4 M | 49 M | 91.4 M | 105.1 M | 110.4 M |
| SPHR | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | 52.6 M | 97 M | 252.7 M | 290.6 M | 305.2 M |
| TFX | 15.3 M | (28.9 M) | (21.7 M) | (7.8 M) | (5.2 M) | 7.6 M | 26.8 M | 164.8 M | 26.7 M | 29.5 M | (12.6 M) | 94 M | (104.2 M) | (119.9 M) | (113.9 M) |
Zura Bio Limited and related stocks such as Merit Medical Systems, Cleantech Power Corp, and Ecoloclean Industrs Change To Liabilities description
My Equities
My Current Equities and Potential Positions
| Zura Bio Limited | ZURA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 2.46
Check out Zura Bio Performance and Zura Bio Correlation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Zura Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.